Look for:

Products

BRIACELL THERAPEUTICS CORP.


ISIN:
CA1079301091
WKN:
107930109

2024/07/17 22:30:00
Price
0.9211 USD
Difference -5.82% (-0.06)

General attributes

ISINCA1079301091
SymbolBCTX
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)15 EUR
BenchmarkS&P/TSX 60 INDEX

Market data

Bid (Bid size)0.8903 USD (1,000)
Ask (Ask size)0.94 USD (100)
Open0.96 USD
High0.9701 USD
Low0.8854 USD
Close (prev. day)0.978 USD
VWAP0.932032 USD
Volume (pcs)92,755
Trading volume86,442.45
Number of trades492
Last size-

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/07/12 en Global Equity Ratings PDF Download
2024/06/21 en Global Equity Ratings PDF Download
2024/06/14 en Global Equity Ratings PDF Download
2024/05/29 en Global Equity Ratings PDF Download
2024/04/26 en Global Equity Ratings PDF Download


2024/07/17 22:30:00
Price
0.9211 USD
Difference -5.82% (-0.06)

General attributes

ISINCA1079301091
SymbolBCTX
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)15 EUR
BenchmarkS&P/TSX 60 INDEX

Market data

Bid (Bid size)0.8903 USD (1,000)
Ask (Ask size)0.94 USD (100)
Open0.96 USD
High0.9701 USD
Low0.8854 USD
Close (prev. day)0.978 USD
VWAP0.932032 USD
Volume (pcs)92,755
Trading volume86,442.45
Number of trades492
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-79.25%-85.79%-80.65%
Perf (abs.)-3.52-5.56-3.84
Beta-0.100.801.32
Volatility95.4185.1279.00
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.9253 USD (201,583)
Ø price 30 days | Ø volume 30 days (pcs.)1.1669 USD (113,307)
Ø price 100 days | Ø volume 100 days (pcs.)2.0542 USD (117,914)
Ø price 250 days | Ø volume 250 days (pcs.)3.9588 USD (105,291)
YTD High | date5.9700 USD (2024/01/02)
YTD Low | date0.8500 USD (2024/07/12)
52 Weeks High | date7.5900 USD (2023/08/28)
52 Weeks Low | date0.8500 USD (2024/07/12)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/07/1722:020.845 EUR0.001
Toronto Stock Exchange2024/07/1720:271.25 CAD0.0026
Stuttgart2024/07/1721:580.835 EUR0.008
Nasdaq2024/07/1722:300.9211 USD0.09492
Munich2024/07/1708:010.88 EUR0.002
Frankfurt2024/07/1708:140.835 EUR0.002
Berlin2024/07/1720:220.835 EUR0.0015

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=150087&ID_TYPE_IMAGE_LOGO=2

Contact Details

BRIACELL THERAPEUTICS
- -
15th Street, Bellevue Centre, Suite 300 235 V7T 2X1 Vancouver
Telefon: +1 604-921-1810
Fax: +1 604-921-1898
E-mail: -

Company Profile

-






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.